CTX and its Role in Managing Patients Exposed to Oral Bisphosphonates

Journal of Oral and Maxillofacial Surgery

Volumn 68, Issue 2, 2010, Pages 487-488

  Dodson, Thomas B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CARBOXY TERMINAL TELOPEPTIDE;

BLOOD SAMPLING; CLINICAL DECISION MAKING; CLINICAL EVALUATION; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIET RESTRICTION; DISEASE COURSE; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; DRUG WITHDRAWAL; ENDODONTICS; GENDER; GEOGRAPHY; HUMAN; JAW OSTEONECROSIS; LABORATORY TEST; LETTER; PATIENT CARE; PHYSICIAN; RISK FACTOR; RISK REDUCTION; SURGICAL TECHNIQUE; TOOTH EXTRACTION; TREATMENT DURATION;

BIOLOGICAL MARKERS; BONE DENSITY CONSERVATION AGENTS; COLLAGEN TYPE I; DIPHOSPHONATES; HUMANS; JAW DISEASES; OSTEONECROSIS; PEPTIDES; RISK; TOOTH EXTRACTION;

EID: 73949156941     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2009.07.088     Document Type: Letter

References (4)

1. Marx R.E., Cillo Jr. J.E., and Ulloa J.J. Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65 (2007) 2397
2. Kunchar R., Need A., Hughes T., et al. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg 67 (2009) 1167
3. Ruggiero S.L., Dodson T.B., Assael L.A., et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws: 2009 Update. J Oral Maxillofac Surg 67 suppl (2009) 2
4. The Quotations Page. http://www.quotationspage.com/quote/14349.html Accessed July 12, 2009